Join Clinical Trials
  • Login
  • Home
  • Clinical Trial Categories
  • Clinical Trials by Condition
  • Bb
  • Brain Tumor, Childhood


Menu

Choose Which Database to Search - Volunteer Database - Clinical Trial Database Create an Account - VOLUNTEER Accounts - RECRUITER Accounts Account Login - Volunteers Login - Recruiters Login Join a Clinical Trial Clinical Trials by Category Clinical Trials by Location Submit a Clinical Trial Frequently Asked Questions Contact Us Sitemap Blog

Categories

    Healthy Volunteers Adults - 18 - 64 Youths - Birth - 17 Seniors - 65 + Expanded Access Compensated Trials Clinical Trials by Condition Trials by Drug Type Trials for Rare Conditions

Recent Listings

  • Post your clinical trial on JoinClinicalTrials.com

    Ellijay, Georgia 30536
    United States

    Post your clinical trial on JoinClinicalTrials.com

    05-09-2019 01:01PM

JoinClinicalTrials.com





  • Cognitive Biomarkers in Pediatric Brain Tumor Patients
    NCT02914067
    Condition:   Childhood Brain Tumor
    Interventions:   Other: Neurocognitive testing;   Device: rsfcMRI
    Sponsors:   Washington University School of Medicine;   Children's Discovery Institute
    Recruiting
  • FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors
    NCT03451123
    Condition:   Pediatric Brain Tumors
    Intervention:   Drug: FET PET/MRI
    Sponsor:   University of Alabama at Birmingham
    Recruiting
  • Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis
    NCT03591861
    Condition:   Pediatric Brain Tumor
    Interventions:   Procedure: Ketogenic diet;   Drug: BCNU
    Sponsor:   Washington University School of Medicine
    Recruiting
  • Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors
    NCT03234309
    Condition:   Childhood Brain Neoplasm
    Interventions:   Drug: Ferumoxytol;   Procedure: Magnetic Resonance Imaging
    Sponsors:   OHSU Knight Cancer Institute;   National Cancer Institute (NCI)
    Recruiting
  • In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI
    NCT03179449
    Condition:   Childhood Brain Neoplasm
    Interventions:   Diagnostic Test: Diagnostic (ferumoxytol-enhanced MRI);   Procedure: Surgery;   Drug: Ferumoxytol;   Other: Tissue Analysis
    Sponsors:   Michael Iv;   National Cancer Institute (NCI)
    Recruiting
  • Understanding the Late Effects of Surviving a Pediatric Brain Tumor
    NCT03208387
    Conditions:   Brain Tumor;   Pediatric Brain Tumor;   Pediatric Cancer
    Interventions:   Diagnostic Test: Diffusion tensor imaging (DTI);   Diagnostic Test: Resting state functional connectivity MRI (rs-fcMRI);   Behavioral: Wechsler Intelligence Scale for Children - 5th edition (WISC-V);   Behavioral: California Verbal Learning Test (CVLT-C);   Behavioral: Beery Test of Visual Motor Integration 6th edition;   Behavioral: Grooved Pegboard;   Behavioral: PedsQL Multidimensional Fatigue Scale;   Diagnostic Test: MRI
    Sponsor:   Memorial Sloan Kettering Cancer Center
    Recruiting
  • International HIT-MED Registry (I-HIT-MED)
    NCT02417324
    Condition:   Childhood Brain Tumor
    Intervention:  
    Sponsor:   Universitätsklinikum Hamburg-Eppendorf
    Recruiting
  • Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors
    NCT03068832
    Condition:   Pediatric Brain Tumor
    Interventions:   Biological: Personalized peptide vaccine;   Drug: Poly ICLC;   Procedure: Peripheral blood draw
    Sponsor:   Washington University School of Medicine
    Not yet recruiting
  • Components of Social Functioning in Survivors of Pediatric Brain Tumors
    NCT03361033
    Conditions:   Brain Tumor, Pediatric;   Medulloblastoma, Pediatric
    Intervention:  
    Sponsors:   St. Jude Children's Research Hospital;   American Cancer Society, Inc.
    Recruiting
  • Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
    NCT02644291
    Conditions:   Medulloblastoma;   Astrocytoma, Grade III;   Glioblastoma;   Anaplastic Astrocytoma;   Brain Stem Neoplasms, Malignant;   Oligodendroblastoma;   Anaplastic Oligodendroglioma;   Malignant Glioma
    Intervention:   Drug: Mebendazole
    Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Recruiting
  • Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
    NCT02372409
    Conditions:   Glioma;   Pilocytic Astrocytoma;   Anaplastic Astrocytoma;   Glioblastoma;   Mixed Oligoastrocytoma;   Mixed Glioma;   Oligodendroglioma;   Optic Glioma;   Astrocytoma
    Interventions:   Device: MRI-guided laser ablation;   Drug: Doxorubicin;   Drug: Etoposide;   Device: Dynamic contrast-enhanced (DCE) MRI;   Device: Dynamic susceptibility contrast (DSC) MRI
    Sponsor:   Washington University School of Medicine
    Recruiting
  • Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
    NCT03904862
    Condition:   Medulloblastoma, Childhood
    Intervention:   Drug: CX 4945
    Sponsors:   Pediatric Brain Tumor Consortium;   St. Jude Children's Research Hospital;   National Cancer Institute (NCI)
    Recruiting
  • Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
    NCT01503086
    Conditions:   Brain Neoplasm;   Recurrent Brain Neoplasm
    Interventions:   Procedure: Cognitive Assessment;   Other: Computer-Assisted Cognitive Training;   Procedure: Psychosocial Assessment and Care;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting
  • Creating a Decision Support System for the Corporate Management of Physical Therapy
    NCT03586401
    Conditions:   Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Brain Tumor;   Physical Activity;   Physical Disability
    Intervention:  
    Sponsor:   Federal Research Institute of Pediatric Hematology, Oncology and Immunology
    Recruiting
  • Re-Irradiation of Progressive or Recurrent DIPG
    NCT03126266
    Condition:   Recurrent or Progressive Diffuse Intrinsic Pontine Glioma
    Intervention:   Radiation: re-irradiation
    Sponsors:   University of Calgary;   Janeway Children's Health and Rehabilitation Centre;   IWK Health Centre;   St. Justine's Hospital;   Montreal Children's Hospital of the MUHC;   CHU de Quebec-Universite Laval;   Children's Hospital of Eastern Ontario;   The Hospital for Sick Children;   McMaster Children's Hospital;   London Health Sciences Centre;   CancerCare Manitoba;   Stollery Children's Hospital;   Alberta Children's Hospital;   British Columbia Children's Hospital
    Recruiting
  • PRecISion Medicine for Children With Cancer
    NCT03336931
    Conditions:   Childhood Cancer;   Childhood Solid Tumor;   Childhood Brain Tumor;   Childhood Leukemia;   Refractory Cancer;   Relapsed Cancer
    Intervention:   Diagnostic Test: Molecular profiling and drug testing
    Sponsors:   Sydney Children's Hospitals Network;   Children's Cancer Institute Australia;   Australian and New Zealand Children's Haematology/Oncology Group;   Garvan Institute of Medical Research;   German Cancer Research Center
    Recruiting
  • HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
    NCT03911388
    Conditions:   Neoplasms, Brain;   Glioblastoma Multiforme;   Glioblastoma of Cerebellum;   Neoplasms;   Astrocytoma;   Astrocytoma, Cerebellar;   Neuroectodermal Tumors;   Neuroectodermal Tumors, Primitive;   Cerebellar PNET, Childhood;   Cerebellar Neoplasms;   Cerebellar Neoplasms, Primary;   Cerebellar Neoplasm, Malignant;   Cerebellar Neoplasm Malignant Primary;   Neoplasm Metastases;   Neoplasm Malignant;   Neoplasms, Neuroepithelial;   Neoplasms, Germ Cell and Embryonal;   Neoplasms by Histologic Type;   Neoplasms, Glandular and Epithelial;   Neoplasms, Nerve Tissue;   Central Nervous System Neoplasms, Primary;   Central Nervous System Neoplasms, Malignant;   Nervous System Neoplasms;   Neoplasms by Site;   Brain Diseases;   Central Nervous System Diseases;   Nervous System Diseases;   Medulloblastoma Recurrent;   HSV;   Virus;   Pediatric Brain Tumor;   Nervous System Cancer;   Primitive Neuroectodermal Tumor (PNET) of Cerebellum
    Intervention:   Biological: G207
    Sponsor:   University of Alabama at Birmingham
    Recruiting
  • Dose Escalation Study of CLR 131 in Children and Adolescents With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
    NCT03478462
    Conditions:   Pediatric Solid Tumor;   Pediatric Lymphoma;   Pediatric Brain Tumor;   DIPG;   Neuroblastoma;   Ewing Sarcoma;   Rhabdomyosarcoma;   Osteosarcoma
    Intervention:   Drug: CLR 131
    Sponsor:   Cellectar Biosciences, Inc.
    Recruiting
  • Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
    NCT03739372
    Conditions:   Glioma;   Glioma of Brain;   Cancer;   Pediatric Cancer;   Pediatric Brain Tumor;   Astrocytoma;   Glioblastoma;   Hemispheric
    Intervention:   Other: Specialized tumor board recommendation
    Sponsors:   University of California, San Francisco;   Pacific Pediatric Neuro-Oncology Consortium
    Recruiting
  • SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
    NCT03434262
    Conditions:   Anaplastic Astrocytoma;   Anaplastic Ependymoma;   Anaplastic Ganglioglioma;   Anaplastic Meningioma;   Anaplastic Oligodendroglioma;   Pleomorphic Xanthoastrocytoma, Anaplastic;   Atypical Teratoid/Rhabdoid Tumor;   Brain Cancer;   Brain Tumor;   Central Nervous System Neoplasms;   Choroid Plexus Carcinoma;   CNS Embryonal Tumor With Rhabdoid Features;   Ganglioneuroblastoma of Central Nervous System;   CNS Tumor;   Embryonal Tumor of CNS;   Ependymoma;   Glioblastoma;   Glioma;   Glioma, Malignant;   Medulloblastoma;   Medulloblastoma; Unspecified Site;   Medulloepithelioma;   Neuroepithelial Tumor;   Neoplasms;   Neoplasms, Neuroepithelial;   Papillary Tumor of the Pineal Region (High-grade Only);   Pediatric Brain Tumor;   Pineal Parenchymal Tumor of Intermediate Differentiation (High-grade Only);   Pineoblastoma;   Primitive Neuroectodermal Tumor;   Recurrent Medulloblastoma;   Refractory Brain Tumor;   Neuroblastoma. CNS;   Glioblastoma, IDH-mutant;   Glioblastoma, IDH-wildtype;   Medulloblastoma, Group 3;   Medulloblastoma, Group 4;   Glioma, High Grade;   Neuroepithelial Tumor, High Grade;   Medulloblastoma, SHH-activated and TP53 Mutant;   Medulloblastoma, SHH-activated and TP53 Wildtype;   Medulloblastoma, Chromosome 9q Loss;   Medulloblastoma, Non-WNT Non-SHH, NOS;   Medulloblastoma, Non-WNT/Non-SHH;   Medulloblastoma, PTCH1 Mutation;   Medulloblastoma, WNT-activated;   Ependymoma, Recurrent;   Glioma, Recurrent High Grade;   Glioma, Recurrent Malignant;   Embryonal Tumor, NOS;   Glioma, Diffuse Midline, H3K27M-mutant;   Embryonal Tumor With Multilayered Rosettes (ETMR);   Ependymoma, NOS, WHO Grade III;   Ependymoma, NOS, WHO Grade II;   Medulloblastoma, G3/G4;   Ependymoma, RELA Fusion Positive
    Interventions:   Drug: Gemcitabine;   Drug: ribociclib;   Drug: sonidegib;   Drug: trametinib;   Biological: filgrastim
    Sponsors:   St. Jude Children's Research Hospital;   Novartis Pharmaceuticals
    Recruiting
  • Ex Vivo Drug Sensitivity Testing and Mutation Profiling
    NCT03860376
    Conditions:   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Large Cell Lymphoma;   Refractory Childhood Acute Lymphoblastic Leukemia;   Refractory Childhood Hodgkin Lymphoma;   Refractory Childhood Malignant Germ Cell Neoplasm;   Recurrent Childhood Brain Tumor;   Recurrent Childhood Brainstem Glioma;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Gliosarcoma;   Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    Intervention:  
    Sponsors:   Florida International University;   Nicklaus Children's Hospital f/k/a Miami Children's Hospital
    Recruiting
  • Methionine PET/CT Studies In Patients With Cancer
    NCT00840047
    Conditions:   Brain Tumors and/or Solid Tumors Including;   Brain Stem Glioma;   High Grade CNS Tumors;   Ependymoma;   Medulloblastoma;   Craniopharyngioma;   Low Grade CNS Tumors;   Hodgkin Lymphoma;   Non Hodgkin Lymphoma;   Ewing Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma;   Neuroblastoma;   Other
    Intervention:   Drug: Methionine
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting
  • Neurobehavioral Outcomes and Quality of Life in Pediatric Patients With Brain or Head/Neck Tumors Receiving Proton or Photon Radiotherapy
    NCT02608762
    Condition:   Brain Tumor
    Intervention:   Radiation: standard adjuvant local radiation therapy or cranial radiation therapy
    Sponsor:   Chang Gung Memorial Hospital
    Recruiting
  • Strict Classic Ketogenic Diet as a Therapy for Recurrent or Progressive and Refractory Brain Tumors in Children
    NCT03955068
    Conditions:   Recurrent Brain Tumor, Childhood;   Ketogenic Diet
    Intervention:   Other: Strict Classic Ketogenic Diet
    Sponsor:   Daniel Bowers
    Not yet recruiting
  • Social Emotional Development in Young Children With Cancer
    NCT03086421
    Conditions:   Solid Tumor, Childhood;   Brain Tumor, Pediatric
    Intervention:   Behavioral: Questionnaires
    Sponsors:   St. Jude Children's Research Hospital;   American Cancer Society, Inc.
    Recruiting
  • Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts
    NCT04158284
    Conditions:   Craniopharyngioma;   Obesity
    Intervention:  
    Sponsors:   Klinikum Oldenburg gGmbH;   Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH);   Deutsche Gesellschaft für Kinderendokrinologie und Diabetologie (DGKED);   Deutsche Gesellschaft für Endokrinologie (DGE);   Arbeitsgemeinschaft Pädiatrische Radioonkologie (APRO);   Deutschen Gesellschaft für Radioonkologie (DEGRO)
    Recruiting
  • The Diagnostic Value of 18F-FET PET/MRI for CNS Tumors in Children and Adolescents
    NCT03402425
    Conditions:   Positron-Emission Tomography;   Brain Neoplasms, Childhood
    Intervention:   Diagnostic Test: 18F-FET PET
    Sponsors:   Rigshospitalet, Denmark;   Børnecancerfonden
    Recruiting
  • A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
    NCT02256137
    Conditions:   Acute Lymphoblastic Leukemia;   Brain Tumor;   Hodgkin Lymphoma
    Intervention:  
    Sponsors:   St. Jude Children's Research Hospital;   National Cancer Institute (NCI)
    Recruiting
  • International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
    NCT02066220
    Condition:   Brain Tumors
    Interventions:   Radiation: Radiotherapy without Carboplatin;   Drug: Reduced-intensity maintenance chemotherapy;   Radiation: Radiotherapy with Carboplatin;   Drug: Maintenance chemotherapy
    Sponsors:   Universitätsklinikum Hamburg-Eppendorf;   Deutsche Kinderkrebsstiftung
    Recruiting
  • Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas
    NCT03696355
    Condition:   Brain and Central Nervous System Tumors
    Interventions:   Drug: GDC-0084;   Radiation: radiation therapy
    Sponsors:   St. Jude Children's Research Hospital;   Kazia Therapeutics Limited
    Recruiting
  • A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma
    NCT01878617
    Condition:   Medulloblastoma
    Interventions:   Radiation: Craniospinal Irradiation with boost to the primary tumor site;   Drug: Cyclophosphamide;   Drug: Cisplatin;   Drug: Vincristine;   Drug: Vismodegib;   Drug: Pemetrexed;   Drug: Gemcitabine;   Other: Aerobic Training;   Other: Neurocognitive Remediation
    Sponsors:   St. Jude Children's Research Hospital;   Genentech, Inc.;   National Cancer Institute (NCI)
    Recruiting
  • Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas
    NCT04101123
    Conditions:   Leukemia;   Brain Tumor;   Sarcoma;   Childhood Cancer;   Cancer;   Adolescent Cancer
    Intervention:   Other: Non-Interventional
    Sponsor:   Martin-Luther-Universität Halle-Wittenberg
    Not yet recruiting
  • Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitor BMS-986158 in Pediatric Cancer
    NCT03936465
    Conditions:   Solid Tumor, Childhood;   Lymphoma;   Brain Tumor, Pediatric
    Intervention:   Drug: BMS-986158
    Sponsors:   Dana-Farber Cancer Institute;   Stand Up To Cancer
    Recruiting
  • Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
    NCT02359565
    Conditions:   Constitutional Mismatch Repair Deficiency Syndrome;   Lynch Syndrome;   Malignant Glioma;   Recurrent Brain Neoplasm;   Recurrent Childhood Ependymoma;   Recurrent Diffuse Intrinsic Pontine Glioma;   Recurrent Medulloblastoma;   Refractory Brain Neoplasm;   Refractory Diffuse Intrinsic Pontine Glioma;   Refractory Ependymoma;   Refractory Medulloblastoma
    Interventions:   Procedure: Diffusion Tensor Imaging;   Procedure: Diffusion Weighted Imaging;   Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging;   Procedure: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging;   Other: Laboratory Biomarker Analysis;   Procedure: Magnetic Resonance Spectroscopic Imaging;   Biological: Pembrolizumab;   Procedure: Perfusion Magnetic Resonance Imaging
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

Popular Now

  • Privacy Policy
  • Ad and Cookie Policy
  • Infringement Policy
  • Terms of Use
  • Email Policy
  • Contact Us
  • Post Clinical Trials
  • Join Clinical Trials
  • Volunteer Login
  • Recruiters Login
  • Frequently Asked Questions
  • Blog
  • Find Clinical Trials
  • Find Volunteers
  • Trials by Category
  • Trials by Location
  • Volunteers by Category
  • Volunteers by Location
All clinical trials are registered and certified with clinicaltrials.gov. Data via U.S. National Library of Medicine,U.S. National Institutes of Health, U.S. Department of Health & Human Services. JoinClinicaltrials.com (Aunica Media llc) is a free resource that provides individuals and companies with information regarding clinical trials that are being conducted nationwide. Aunica Media llc does not conduct clinical trials nor endorses them. Please consult your doctor or physician before participating. And Ye shall know the truth, and the truth shall make you free
©2001-2019 Aunica Media LLC